Published in Lab Business Week, May 28th, 2006
For the fourth fiscal quarter ended March 31, 2006, Abaxis reported revenues of $19.8 million, as compared with revenues of $13.8 million for the comparable period last year, an increase of 43%. Instrument revenue, reagent disc and hematology reagent revenue increased by $5.1 million or 39% over the same period last year. The company reported net income attributable to common shareholders of $2.3 million, compared to $1.3 million for the same period last year.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.